Literature DB >> 18058834

Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan.

Jur-Shan Cheng1, Weng-Foung Huang, Keh-Ming Lin, Yaw-Tang Shih.   

Abstract

OBJECTIVE: To investigate benzodiazepine usage and the characteristics associated with usage among elderly outpatients in Taiwan.
METHODS: This was an observational study of subjects who were enrolled in the National Health Insurance program and aged at least 65 in 2002. They were grouped according to treatment period and mean dosage. An ordered logit regression model was used to evaluate associations of characteristics with benzodiazepine usage.
RESULTS: Of the 4,267 elderly people included, 1,826 had received at least one prescription for benzodiazepines. The 1-year prevalence of benzodiazepine usage by elderly outpatients was approximately 43%. Characteristics associated with receiving benzodiazepine therapy included female gender, displaying comorbid insomnia, anxiety, depression, other mental diseases, cardiovascular disease, cancer, chronic obstructive pulmonary disease, arthritis, and previous use of benzodiazepines. Individuals older than 75 years, with comorbid insomnia, anxiety, depression, other mental diseases, cardiovascular disease, cancer, being in previous receipt of benzodiazepines, or high prescription-overlap ratio were more likely to receive longer treatment. Individuals with insomnia, anxiety, depression, and previous use of higher cumulative dosage of benzodiazepine were more likely to receive higher-dosage therapy.
CONCLUSIONS: Mental disorders and previous exposure to higher cumulative dosages of benzodiazepines are associated with an increased likelihood of receiving benzodiazepine therapy, longer treatment, and a higher mean dosage. Older individuals, less likely to receive higher dosage benzodiazepine therapy, are more likely to receive more prolonged therapy. Women are more likely to receive benzodiazepine therapy, but both men and women have comparable benzodiazepine usage patterns.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18058834     DOI: 10.1002/gps.1950

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  15 in total

1.  Benzodiazepine discontinuation among community-dwelling older people: a population-based cohort study.

Authors:  J Simon Bell; Piia Lavikainen; Mikko Korhonen; Sirpa Hartikainen
Journal:  Eur J Clin Pharmacol       Date:  2010-09-15       Impact factor: 2.953

2.  Measuring psychotropic drug exposures in register-based studies--validity of a dosage assumption of one unit per day in older Finns.

Authors:  Maria Rikala; Sirpa Hartikainen; Leena K Saastamoinen; Maarit Jaana Korhonen
Journal:  Int J Methods Psychiatr Res       Date:  2013-05-16       Impact factor: 4.035

3.  Sedative load among community-dwelling people aged 75 years and older: a population-based study.

Authors:  Heidi T Taipale; J Simon Bell; Maija Uusi-Kokko; Eija Lönnroos; Raimo Sulkava; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2011-11-01       Impact factor: 3.923

4.  Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis.

Authors:  Louis Jacob; Michael A Rapp; Karel Kostev
Journal:  Ther Adv Psychopharmacol       Date:  2017-03-01

5.  Exploring emergency physicians' knowledge, attitudes, and behaviour towards Choosing Wisely in Taiwan.

Authors:  Wang-Chuan Juang; Sonia Ming-Jiu Chiou; Hui-Ling Yang; Ying-Chun Li
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

Review 6.  Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria.

Authors:  Fabiane Raquel Motter; Janaína Soder Fritzen; Sarah Nicole Hilmer; Érika Vieira Paniz; Vera Maria Vieira Paniz
Journal:  Eur J Clin Pharmacol       Date:  2018-03-27       Impact factor: 2.953

7.  Trends in benzodiazepine receptor agonists use and associated factors in the Belgian general older population: analysis of the Belgian health interview survey data.

Authors:  Catherine Pétein; Anne Spinewine; Séverine Henrard
Journal:  Ther Adv Psychopharmacol       Date:  2021-05-25

Review 8.  Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis.

Authors:  Corrado Barbui; Andrea Cipriani; Vikram Patel; José L Ayuso-Mateos; Mark van Ommeren
Journal:  Br J Psychiatry       Date:  2011-01       Impact factor: 9.319

9.  Is long-term use of benzodiazepine a risk for cancer?

Authors:  Usman Iqbal; Phung-Anh Nguyen; Shabbir Syed-Abdul; Hsuan-Chia Yang; Chih-Wei Huang; Wen-Shan Jian; Min-Huei Hsu; Yun Yen; Yu-Chuan Jack Li
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

10.  Benzodiazepine use and risk of Alzheimer's disease: case-control study.

Authors:  Sophie Billioti de Gage; Yola Moride; Thierry Ducruet; Tobias Kurth; Hélène Verdoux; Marie Tournier; Antoine Pariente; Bernard Bégaud
Journal:  BMJ       Date:  2014-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.